Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	ATM Offering	Direct Offering	Follow on Offering	Common Stock	Common Stock ATM Offering	Common Stock Direct Offering	Common Stock Follow on Offering	Additional Paid-In-Capital	Additional Paid-In-Capital ATM Offering	Additional Paid-In-Capital Direct Offering	Additional Paid-In-Capital Follow on Offering	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at beginning at Dec. 31, 2022	$ 326,562				$ 5				$ 748,857				$ 37	$ (422,337)
Balance at beginning (in shares) at Dec. 31, 2022					46,865,206
Exercise of stock options	456								456
Exercise of stock options (in shares)					105,783
Common stock issued for Vested restricted stock units, Shares					8,067
Vested warrants issued pursuant to loan agreement	330								330
Stock-based compensation expense	4,844								4,844
Net unrealized loss on marketable securities	(16)												(16)
Net loss	(25,831)													(25,831)
Balance at ending at Mar. 31, 2023	306,345				$ 5				754,487				21	(448,168)
Balance at ending (in shares) at Mar. 31, 2023					46,979,056
Balance at beginning at Dec. 31, 2022	326,562				$ 5				748,857				37	(422,337)
Balance at beginning (in shares) at Dec. 31, 2022					46,865,206
Net unrealized loss on marketable securities	(288)
Net loss	(56,914)
Balance at ending at Jun. 30, 2023	616,437				$ 6				1,095,933				(251)	(479,251)
Balance at ending (in shares) at Jun. 30, 2023					55,547,959
Balance at beginning at Dec. 31, 2022	326,562				$ 5				748,857				37	(422,337)
Balance at beginning (in shares) at Dec. 31, 2022					46,865,206
Net loss	(151,759)
Balance at ending at Dec. 31, 2023	535,306				$ 6				1,109,126				270	(574,096)
Balance at ending (in shares) at Dec. 31, 2023					55,754,445
Balance at beginning at Mar. 31, 2023	306,345				$ 5				754,487				21	(448,168)
Balance at beginning (in shares) at Mar. 31, 2023					46,979,056
Exercise of stock options	1,556								1,556
Exercise of stock options (in shares)					306,510
Common stock issued for Vested restricted stock units, Shares					9,956
Issuance of common stock pursuant to ESPP purchases	313								313
Issuance of common stock pursuant to ESPP purchases (in shares)					7,885
Issuance of common stock, net of issuance costs		$ 123,824	$ 210,956				$ 1			$ 123,824	$ 210,955
Issuance of common stock (in shares)						3,006,052	5,238,500
Stock-based compensation expense	4,798								4,798
Net unrealized loss on marketable securities	(272)												(272)
Net loss	(31,083)													(31,083)
Balance at ending at Jun. 30, 2023	616,437				$ 6				1,095,933				(251)	(479,251)
Balance at ending (in shares) at Jun. 30, 2023					55,547,959
Balance at beginning at Dec. 31, 2023	535,306				$ 6				1,109,126				270	(574,096)
Balance at beginning (in shares) at Dec. 31, 2023					55,754,445
Exercise of stock options	1,769								1,769
Exercise of stock options (in shares)					233,321
Common stock issued for Vested restricted stock units, Shares					10,663
Vested warrants issued pursuant to loan agreement	431								431
Issuance of common stock, net of issuance costs		$ 10,604		$ 344,438				$ 1		$ 10,604		$ 344,437
Issuance of common stock (in shares)						500,000		12,650,000
Stock-based compensation expense	7,398								7,398
Net unrealized loss on marketable securities	(349)												(349)
Net loss	(53,344)													(53,344)
Balance at ending at Mar. 31, 2024	846,253				$ 7				1,473,765				(79)	(627,440)
Balance at ending (in shares) at Mar. 31, 2024					69,148,429
Balance at beginning at Dec. 31, 2023	$ 535,306				$ 6				1,109,126				270	(574,096)
Balance at beginning (in shares) at Dec. 31, 2023					55,754,445
Exercise of stock options (in shares)	233,655
Net unrealized loss on marketable securities	$ (531)
Net loss	(109,331)
Balance at ending at Jun. 30, 2024	798,067				$ 7				1,481,748				(261)	(683,427)
Balance at ending (in shares) at Jun. 30, 2024					69,205,668
Balance at beginning at Mar. 31, 2024	846,253				$ 7				1,473,765				(79)	(627,440)
Balance at beginning (in shares) at Mar. 31, 2024					69,148,429
Exercise of stock options	3								3
Exercise of stock options (in shares)					334
Common stock issued for Vested restricted stock units, Shares					40,661
Issuance of common stock pursuant to ESPP purchases	324								324
Issuance of common stock pursuant to ESPP purchases (in shares)					16,244
Stock-based compensation expense	7,656								7,656
Net unrealized loss on marketable securities	(182)												(182)
Net loss	(55,987)													(55,987)
Balance at ending at Jun. 30, 2024	$ 798,067				$ 7				$ 1,481,748				$ (261)	$ (683,427)
Balance at ending (in shares) at Jun. 30, 2024					69,205,668